NEUROCRINE BIOSCIENCES INC COM STK USD0.001NEUROCRINE BIOSCIENCES INC COM STK USD0.001NEUROCRINE BIOSCIENCES INC COM STK USD0.001

NEUROCRINE BIOSCIENCES INC COM STK USD0.001

No trades
See on Supercharts
Market capitalization
‪13.83 B‬USD
‪249.70 M‬USD
‪1.89 B‬USD
‪96.92 M‬
Beta (1Y)
0.59

About NEUROCRINE BIOSCIENCES INC COM STK USD0.001

CEO
Kevin Charles Gorman
Headquarters
San Diego
Employees (FY)
‪1.4 K‬
Founded
1992
FIGI
BBG00JVRFVK7
Neurocrine Biosciences, Inc. is a neuroscience-focused, biopharmaceutical company, which engages in the research, development, and commercialization of pharmaceuticals for the treatment of neurological, neuroendocrine, and neuropsychiatric disorders. The company was founded by Kevin C. Gorman and Wylie W. Vale in January 1992 and is headquartered in San Diego, CA.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Curated watchlists where 0K6R is featured.

Frequently Asked Questions

The current price of 0K6R is 136.70 USD — it has decreased by 1.30% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on LSE exchange NEUROCRINE BIOSCIENCES INC COM STK USD0.001 stocks are traded under the ticker 0K6R.
NEUROCRINE BIOSCIENCES INC COM STK USD0.001 is going to release the next earnings report on May 1, 2024. Keep track of upcoming events with our Earnings Calendar.
0K6R stock is 3.06% volatile and has beta coefficient of 0.59. Check out the list of the most volatile stocks — is NEUROCRINE BIOSCIENCES INC COM STK USD0.001 there?
0K6R earnings for the last quarter are 0.82 USD per share, whereas the estimation was 1.04 USD resulting in a −21.11% surprise. The estimated earnings for the next quarter are 1.21 USD per share. See more details about NEUROCRINE BIOSCIENCES INC COM STK USD0.001 earnings.
NEUROCRINE BIOSCIENCES INC COM STK USD0.001 revenue for the last quarter amounts to ‪498.80 M‬ USD despite the estimated figure of ‪479.09 M‬ USD. In the next quarter revenue is expected to reach ‪518.52 M‬ USD.
Yes, you can track NEUROCRINE BIOSCIENCES INC COM STK USD0.001 financials in yearly and quarterly reports right on TradingView.
0K6R stock has risen by 2.10% compared to the previous week, the month change is a 3.36% fall, over the last year NEUROCRINE BIOSCIENCES INC COM STK USD0.001 has showed a 34.38% increase.
0K6R net income for the last quarter is ‪147.70 M‬ USD, while the quarter before that showed ‪83.10 M‬ USD of net income which accounts for 77.74% change. Track more NEUROCRINE BIOSCIENCES INC COM STK USD0.001 financial stats to get the full picture.
Today NEUROCRINE BIOSCIENCES INC COM STK USD0.001 has the market capitalization of ‪13.83 B‬, it has increased by 0.50% over the last week.
No, 0K6R doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, 0K6R shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade NEUROCRINE BIOSCIENCES INC COM STK USD0.001 stock right from TradingView charts — choose your broker and connect to your account.
0K6R reached its all-time high on Mar 21, 2024 with the price of 148.35 USD, and its all-time low was 67.30 USD and was reached on Jan 2, 2019.
See other stocks reaching their highest and lowest prices.
As of Apr 25, 2024, the company has ‪1.40 K‬ employees. See our rating of the largest employees — is NEUROCRINE BIOSCIENCES INC COM STK USD0.001 on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So NEUROCRINE BIOSCIENCES INC COM STK USD0.001 technincal analysis shows the buy rating today, and its 1 week rating is strong buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating NEUROCRINE BIOSCIENCES INC COM STK USD0.001 stock shows the buy signal. See more of NEUROCRINE BIOSCIENCES INC COM STK USD0.001 technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on NEUROCRINE BIOSCIENCES INC COM STK USD0.001 future price: according to them, 0K6R price has a max estimate of 200.00 USD and a min estimate of 106.00 USD. Read a more detailed NEUROCRINE BIOSCIENCES INC COM STK USD0.001 forecast: see what analysts think of NEUROCRINE BIOSCIENCES INC COM STK USD0.001 and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. NEUROCRINE BIOSCIENCES INC COM STK USD0.001 EBITDA is ‪416.10 M‬ USD, and current EBITDA margin is 22.05%. See more stats in NEUROCRINE BIOSCIENCES INC COM STK USD0.001 financial statements.